Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aveir DR i2i Study

NCT: NCT05252702 · COMPLETED

NCT IDNCT05252702
StatusCOMPLETED
Start Date2022-02-02
Completion2026-02-03
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective, non-randomized, multi-center, international study designed to evaluate the safety and effectiveness of the Aveir™ Dual-Chamber (DR) Leadless Pacemaker system.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑